Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Autologous Matrix-Induced Chondrogenesis (AMIC)
... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Collagen Material, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$175.6 Million by the ... Read More
-
Neuromodulation
... 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. ... Read More
-
Orthopedic Veterinary Implants
... at a CAGR of 6.7% over the analysis period 2024-2030. Veterinary Bone Plates, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$86.4 Million by the end ... Read More
-
Polycystic Ovary Syndrome (PCOS) Treatment
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Insulin-Sensitizing Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion ... Read More
-
Renal Denervation Technologies
... at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based Renal Denervation, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the ... Read More
-
Cancer Cachexia
... CAGR of 5.7% over the analysis period 2024-2030. Progestogens Therapy, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Gastroesophageal Reflux Disease (GERD) Therapeutics
... Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Antacids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.6 Billion by ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional Surgery, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of ... Read More
-
Hypertrophic and Keloid Scar Treatment
... Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Topical Treatment, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$7.3 Billion ... Read More
-
Orthopedic Prosthetic Implants
... at a CAGR of 4.5% over the analysis period 2024-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Respiratory Care Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Therapeutic Devices, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$15.7 Billion by the end of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... reach US$57.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach ... Read More
-
Cystic Fibrosis Therapeutics
... at a CAGR of 15.2% over the analysis period 2024-2030. Cystic Fibrosis Treatment Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion by the ... Read More
-
Overactive Bladder (OAB) Therapeutics
... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Anticholinergics, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$614.7 Million by the end ... Read More
-
Vertebral Compression Fracture Devices
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by ... Read More
-
In Vitro Fertilization Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
... improvements in reproductive technologies, increased awareness, postponed pregnancies, government assistance, expanding healthcare infrastructure, and growing desire for fertility preservation are some of the major factors propelling the IVF industry. The report In Vitro Fertilization Market ... Read More
-
Assisted Reproductive Technology
... at a CAGR of 4.9% over the analysis period 2024-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end ... Read More
-
Neurology Devices
... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by ... Read More
-
Smoking Cessation and Nicotine De-Addiction Products
... reach US$54.9 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. E-cigarettes, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$43.5 ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generic Drugsone of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
Breast Reconstruction
... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$629.5 Million by the end of the analysis ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Orthopedic Braces & Supports, one of the segments analyzed in the report, is expected to record a ... Read More
-
Hip Resurfacing Implants
... at a CAGR of 2.9% over the analysis period 2024-2030. Hybrid Alloy Material, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$128.9 Million by the end ... Read More
Research Assistance
